Bosentan therapy for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A systemic review and meta-analysis.

Xinwang ChenZhen-Guo ZhaiKe HuangWanmu XieJun WanChen Wang

Published in: The clinical respiratory journal (2018)

Bosentan is effective in treating PAH, whereas it improves only certain hemodynamic parameters of CTEPH. Incidence of liver function abnormality is higher in bosentan treatment.

Keyphrases

pulmonary arterial hypertension
pulmonary hypertension
pulmonary artery
risk factors
coronary artery
polycyclic aromatic hydrocarbons